Jonathan Chung to Carcinoma
This is a "connection" page, showing publications Jonathan Chung has written about Carcinoma.
Connection Strength
0.480
-
Exceptional response to olaparib in BRCA2-altered urothelial carcinoma after PD-L1 inhibitor and chemotherapy failure. Eur J Cancer. 2018 06; 96:128-130.
Score: 0.480